Suppr超能文献

原发性纵隔生殖细胞肿瘤患者的生存结局:一项单机构回顾性研究经验

Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience.

作者信息

Yaegashi Hiroshi, Nohara Takahiro, Shigehara Kazuyoshi, Izumi Kouji, Kadono Yoshifumi, Makino Tomoyuki, Yamashita Kaname, Ohtsubo Koushiro, Ikeda Hiroko, Mizokami Atsushi

机构信息

Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.

出版信息

Cancer Diagn Progn. 2022 May 3;2(3):352-359. doi: 10.21873/cdp.10116. eCollection 2022 May-Jun.

Abstract

BACKGROUND/AIM: Primary mediastinal non-seminomatous germ cell tumors (PMNSGCTs) are occasionally complicated by a hematologic malignancy, as with somatic-type malignant tumors called germ cell tumors with somatic-type malignancy (GCTSTM) and are known to have a poor prognosis.

PATIENTS AND METHODS

Data obtained between September 1997 and February 2020 for patients with mediastinal germ cell tumor at our institution were retrospectively analyzed. Key outcome measures included survival rates and the clinical features of non-seminoma cases.

RESULTS

Of 16 patients, 9 had pure seminoma, and 7 had non-seminoma. At the median follow-up of 56.2 months, the 5-year survival rate was significantly higher in patients with seminoma (100%) than in those with non-seminoma (37%) (log-rank test, p=0.0153). Regarding PMNSGCT, two patients evolved into GCTSTM and three had concomitant hematological malignancies.

CONCLUSION

Patients with PMNSGCTs, GCTSTM complications, and hematologic malignancies showed poor survival, suggesting the need for the development of treatment strategies.

摘要

背景/目的:原发性纵隔非精原细胞性生殖细胞肿瘤(PMNSGCTs)偶尔会并发血液系统恶性肿瘤,就像伴有体细胞型恶性肿瘤的生殖细胞肿瘤(GCTSTM)这种体细胞型恶性肿瘤一样,并且已知其预后较差。

患者与方法

对1997年9月至2020年2月期间在我们机构就诊的纵隔生殖细胞肿瘤患者的数据进行回顾性分析。主要结局指标包括生存率和非精原细胞瘤病例的临床特征。

结果

16例患者中,9例为纯精原细胞瘤,7例为非精原细胞瘤。在中位随访56.2个月时,精原细胞瘤患者的5年生存率(100%)显著高于非精原细胞瘤患者(37%)(对数秩检验,p = 0.0153)。关于PMNSGCT,2例患者发展为GCTSTM,3例伴有血液系统恶性肿瘤。

结论

患有PMNSGCTs、GCTSTM并发症和血液系统恶性肿瘤的患者生存率较差,这表明需要制定治疗策略。

相似文献

1
Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience.
Cancer Diagn Progn. 2022 May 3;2(3):352-359. doi: 10.21873/cdp.10116. eCollection 2022 May-Jun.
2
Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre.
Ann Diagn Pathol. 2021 Aug;53:151763. doi: 10.1016/j.anndiagpath.2021.151763. Epub 2021 May 26.
3
Primary mediastinal germ cell tumors - A retrospective analysis of >30 years of experience in a single institution.
Thorac Cancer. 2021 Mar;12(6):807-813. doi: 10.1111/1759-7714.13859. Epub 2021 Jan 27.
4
Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting.
Ecancermedicalscience. 2021 Feb 11;15:1186. doi: 10.3332/ecancer.2021.1186. eCollection 2021.
5
Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan.
Int J Clin Oncol. 2024 Nov;29(11):1756-1761. doi: 10.1007/s10147-024-02607-y. Epub 2024 Sep 5.
6
Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.
Curr Oncol. 2020 Dec 8;28(1):78-85. doi: 10.3390/curroncol28010010.
7
Durable response achieved using Pazopanib for germ tumor cells: A case report.
Mol Clin Oncol. 2021 Mar;14(3):48. doi: 10.3892/mco.2021.2210. Epub 2021 Jan 19.
10
Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia.
Ann Hematol. 2017 Sep;96(9):1435-1439. doi: 10.1007/s00277-017-3037-3. Epub 2017 Jun 3.

引用本文的文献

1
Anemic retinopathy as the presenting symptom of a mediastinal germ cell tumor.
Am J Ophthalmol Case Rep. 2025 Jun 27;39:102374. doi: 10.1016/j.ajoc.2025.102374. eCollection 2025 Sep.
2
3
Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan.
Int J Clin Oncol. 2024 Nov;29(11):1756-1761. doi: 10.1007/s10147-024-02607-y. Epub 2024 Sep 5.
4
Pure mediastinal seminoma about a case report.
Radiol Case Rep. 2023 Aug 1;18(10):3565-3571. doi: 10.1016/j.radcr.2023.07.036. eCollection 2023 Oct.
5
[Development of A Nomogram for Predicting Survival of Patients 
with Primary Mediastinal Germ Cell Tumor Based on SEER Database].
Zhongguo Fei Ai Za Zhi. 2023 Mar 20;26(3):193-203. doi: 10.3779/j.issn.1009-3419.2023.102.11.

本文引用的文献

1
Histiocytic sarcoma following combination chemotherapy for primary mediastinal germ cell tumor: a diagnostic dilemma.
Int Cancer Conf J. 2021 Jan 9;10(2):144-148. doi: 10.1007/s13691-020-00467-7. eCollection 2021 Apr.
2
Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting.
Ecancermedicalscience. 2021 Feb 11;15:1186. doi: 10.3332/ecancer.2021.1186. eCollection 2021.
3
Durable response achieved using Pazopanib for germ tumor cells: A case report.
Mol Clin Oncol. 2021 Mar;14(3):48. doi: 10.3892/mco.2021.2210. Epub 2021 Jan 19.
4
Primary mediastinal germ cell tumors: Survival outcomes and prognostic factors - 10 years experience from a tertiary care institute.
Rare Tumors. 2020 Nov 18;12:2036361320972220. doi: 10.1177/2036361320972220. eCollection 2020.
5
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.
J Clin Invest. 2020 Dec 1;130(12):6668-6676. doi: 10.1172/JCI139682.
6
Neutrophil-to-lymphocyte ratio in primary mediastinal germ cell tumors: A retrospective analysis of >20 years single institution experience.
Curr Probl Cancer. 2020 Aug;44(4):100537. doi: 10.1016/j.currproblcancer.2020.100537. Epub 2020 Jan 16.
7
Germ Cell Tumors with Malignant Somatic Transformation: A Mayo Clinic Experience.
Oncol Res Treat. 2019;42(3):95-100. doi: 10.1159/000495802. Epub 2019 Feb 27.
10
Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia.
Ann Hematol. 2017 Sep;96(9):1435-1439. doi: 10.1007/s00277-017-3037-3. Epub 2017 Jun 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验